← Back to Patent Explorer
US4112076A Expired / Lapsed US ⏱️ 0.0 years remaining

Epi-daunomycin and epi-adriamycin compounds and method of use

Assignee: Pfizer Italia SRL
•
Filing: 1976-04-09
•
Granted: 1978-09-05
•
Expires: 1996-04-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed is a process for preparing glycoside antitumor antibiotics, including the known compounds daunomycin, adriamycin, 4'-epi-daunomycin and 4'-epi-adriamycin and the novel antibiotics, 3',4'-epi-6'-hydroxydaunomycin, 3',4'-epi-6'-hydroxyadriamycin. 3',4'-epi-daunomycin, 3',4'-epi-adriamycin, 4-demethoxy-4'-epi-daunomycin and 4-demethoxy-4'-epi-adriamycin. Process involves reacting daunomycinone or 4-demethoxy-daunomycinone with a protected 1-halo derivative of 3,4-epi-6-hydroxydaunosamine, 3,4-epi-daunosamine or 4-epi-daunosamine in an inert solvent in the presence of a soluble silver salt catalyst to form a protected derivative of the glycoside antibiotic and removing the protecting groups.

Inventors

  • 👤 Federico Arcamone
  • 👤 Alberto Bargiotti
  • 👤 Aurelio Di Marco
  • 👤 Sergio Penco

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 12:03
CPC Classifications
C; C07; C07H; C07H15/00; C07H15/20; C07H15/24; C07H15/252; A; A61; A61P; A61P35/00; C07H5/00; C07H5/04; C07H5/06; G; G04; G04B; G04B37/00; G04B37/0008; G04B37/0025; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 16 words
A glycosidic compound selected from the group consisting of 3'-4'-epi-6'-hydroxy-daunomycin; 3'-4'-epi-6'-hydroxy-adriamycin; 3'-4'-epi-daunomycin; 3'-4'-epi-adriamycin; 4-demethoxy-4'-epi-daunomycin and 4-demethoxy-4'-epi-adriamycin.
Claim 2
Dependent Claim 16 words
A glycosidic compound selected from the group consisting of 3'-4'-epi-6'-hydroxy-daunomycin; 3'-4'-epi-6'-hydroxy-adriamycin; 3'-4'-epi-daunomycin; 3'-4'-epi-adriamycin; 4-demethoxy-4'-epi-daunomycin and 4-demethoxy-4'-epi-adriamycin.
Claim 3
Dependent Claim 11 words
A compound according to claim 1, which is 3'-4'-epi-6'-hydroxy-daunomycin (α anomer).
Claim 4
Dependent Claim 11 words
A compound according to claim 1, which is 3'-4'-epi-6'-hydroxy-adriamycin (α anomer).
Claim 5
Dependent Claim 11 words
A compound according to claim 1, which is 3'-4'-epi-daunomycin (α anomer).
Claim 6
Dependent Claim 11 words
A compound according to claim 1, which is 3'-4'-epi-adriamycin (α anomer).
Claim 7
Dependent Claim 11 words
A compound according to claim 1, which is 4-demethoxy-4'-epi-daunomycin (α anomer).
Claim 8
Dependent Claim 11 words
A compound according to claim 1, which is 4'-demethoxy-4'-epi-adriamycin (α anomer).
Claim 9
Independent Claim 69 words
A method of inhibiting the growth of a tumor selected from the group consisting of Moloney Sarcoma Virus, Ascites lymphocitic P. 388 leukemia, L1210 leukemia, Ascites Sarcoma 180 and Solid Sarcoma 180 which comprises intraperitoneally administering to a host afflicted with said tumor an amount of a compound selected from the group consisting of 3'-4'-epi-6'-hydroxy-daunomycin; 3'-4'-epi-6'-hydroxy-adriamycin; 3'-4'-epi-duanomycin; 3'-4'-epi-adriamycin; 4-demethoxy-4'-epi-daunomycin and 4-demethoxy-4'-epi-adriamycin sufficient to inhibit the growth of said tumor.
Claim 10
Independent Claim 69 words
A method of inhibiting the growth of a tumor selected from the group consisting of Moloney Sarcoma Virus, Ascites lymphocitic P. 388 leukemia, L1210 leukemia, Ascites Sarcoma 180 and Solid Sarcoma 180 which comprises intraperitoneally administering to a host afflicted with said tumor an amount of a compound selected from the group consisting of 3'-4'-epi-6'-hydroxy-daunomycin; 3'-4'-epi-6'-hydroxy-adriamycin; 3'-4'-epi-duanomycin; 3'-4'-epi-adriamycin; 4-demethoxy-4'-epi-daunomycin and 4-demethoxy-4'-epi-adriamycin sufficient to inhibit the growth of said tumor.

References Cited (Backward Citations)

US3803124A Cited
US4046878A Cited
US4025623A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-09-04 1982-03-06 1982-09-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-09-04 1986-03-06 1986-09-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-09-04 1990-03-06 1990-09-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag